BEQVEZ is an FDA-approved, one-time gene therapy infusion for eligible adults with moderate to severe hemophilia B

style
Hidden

BEQVEZ is an FDA-approved, one-time gene therapy infusion for eligible adults with moderate to severe hemophilia B

style
No-padding
Kicker
Kicker
style
desktop-show
Kicker
Kicker
style
mobile-show

Get to know Tim and Bill, real BEQVEZ patients who received their one-time gene therapy infusion in 2021 and 2016, respectively.*

*Bill and Tim participated in the BEQVEZ clinical studies. They were compensated for sharing their stories. Their words and opinions are their own. BEQVEZ is not approved for use in females.

Watch real stories
style
No-padding
BEQVEZ offers a chance at bleed protection without the need for factor IX prophylaxis (FIX prophy)†:

One-time infusion

Safety profile, studied since 2015

†Individual results and duration of effect may vary. The main BEQVEZ study is ongoing to assess the long-term efficacy and safety of BEQVEZ. On-demand FIX may still be required.

Ready to talk to your doctor about BEQVEZ?

Take a 2-minute survey to create your own personalized discussion guide that you can bring with you to your next appointment.

Get your personalized guide

Support and access at every step

Whether you are considering BEQVEZ or already have a prescription, support is available at every step of the journey.

Expand your support team

Stay connected

Get information and educational tools that can help you learn more about BEQVEZ delivered to your inbox.

Sign up today

25+ years

BEQVEZ is a gene therapy from Pfizer—representing our commitment of over 25 years to the hemophilia community
prev-page
next-page
Why gene therapy?